Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.
Giorgos-Konstantinos PapadimasCharalampos KokkinisSophia XirouMargarita ChrysanthouEvangelia KararizouConstantinos PapadopoulosPublished in: Rheumatology international (2019)
Polymyositis with mitochondrial pathology (PM-Mito) is a rare form of idiopathic inflammatory myopathy with no definite diagnostic criteria and similarities to both PM and sporadic inclusion body myositis (s-IBM). The aim of this study is to address the dilemma of whether PM-Mito is a subtype of inflammatory myopathy or represents a disease falling into the spectrum of s-IBM. Herein, we report four female patients diagnosed with PM-Mito, highlighting their rather atypical clinical and histopathological characteristics that seem to indicate a diagnosis away from s-IBM. Muscle weakness was rather proximal and symmetrical and lacked the selective pattern observed in s-IBM. Patients had large-scale deletions in mtDNA, reflecting the mitochondrial component in the pathology of the disease. Conclusively, our study adds to the limited data in the literature on whether PM-Mito is a distinct form of myositis or represents a prodromal stage of s-IBM. Although the latter seems to be supported by a substantial body of evidence, there are, however, important differences, such as the different patterns of muscle weakness, and the good response to treatment observed in some patients. Larger-scale studies are certainly needed to clarify pathogenesis and clinical characteristics of PM-Mito patients, especially in therapeutic and prognostic terms.
Keyphrases
- end stage renal disease
- ejection fraction
- particulate matter
- newly diagnosed
- air pollution
- chronic kidney disease
- systematic review
- prognostic factors
- interstitial lung disease
- heavy metals
- skeletal muscle
- late onset
- polycyclic aromatic hydrocarbons
- gene expression
- genome wide
- rheumatoid arthritis
- patient reported outcomes
- electronic health record
- systemic sclerosis
- big data
- smoking cessation
- mitochondrial dna